OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pregnancy Outcomes in Pregnant Women with HIV on Tenofovir Disoproxil Fumarate (TDF) Compared to Tenofovir Alafenamide (TAF)
Matthew A. Thimm, Alison Livingston, Rosemary Ramroop, et al.
Journal of AIDS and HIV Treatment (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV
Ahizechukwu C. Eke, Mark Mirochnick, Shahin Lockman
New England Journal of Medicine (2023) Vol. 388, Iss. 4, pp. 344-356
Open Access | Times Cited: 30

Application of a Physiologically Based Pharmacokinetic Approach to Predict Tenofovir Pharmacokinetics During Pregnancy
Khaled Abduljalil, Maïlys De Sousa Mendes, Farzaneh Salem, et al.
The AAPS Journal (2025) Vol. 27, Iss. 1
Closed Access

Society for Maternal-Fetal Medicine Consult Series #69: Hepatitis B in pregnancy: updated guidelines
Martina L. Badell, Malavika Prabhu, Jodie A. Dionne, et al.
American Journal of Obstetrics and Gynecology (2023) Vol. 230, Iss. 4, pp. B2-B11
Open Access | Times Cited: 7

Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes
Huey‐Ling Chen, Chien‐Nan Lee, Chin‐Hao Chang, et al.
Liver International (2024) Vol. 44, Iss. 6, pp. 1422-1434
Closed Access | Times Cited: 2

A systematic review and meta-analysis of maternal weight changes and pregnancy outcomes associated with integrase inhibitors and tenofovir alafenamide in pregnant women with HIV
Ahizechukwu Chigoziem Eke, Malini Ramaiyer, George Uchenna Eleje, et al.
American Journal of Obstetrics & Gynecology MFM (2024) Vol. 6, Iss. 8, pp. 101406-101406
Closed Access | Times Cited: 2

Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential
Alexis C. Henderson, Preetam Cholli, Margaret A. Lampe, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 4, pp. 153-167
Open Access | Times Cited: 1

Understanding clinical outcome measures reported in HIV pregnancy studies involving antiretroviral-naive and antiretroviral-experienced women
Ahizechukwu C. Eke, Rahel D. Gebreyohannes, Anna Powell
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. e151-e159
Open Access | Times Cited: 4

Pharmacokinetic and toxicological considerations affecting antiretroviral drug dosing in pregnant women
Zoran Todorović, Gordana Dragović, Relja Lukić
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 6, pp. 419-437
Closed Access

Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection
Emmanuella Chinonso Osuala, Anushka Naidoo, Kelly E. Dooley, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 939-957
Open Access | Times Cited: 1

Adherence Predictors in Pregnant Women Living with HIV on Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate.
Ahizechukwu C. Eke
PubMed (2022) Vol. 5, Iss. 1, pp. 585-593
Closed Access | Times Cited: 2

Page 1

Scroll to top